Detection of the JAK2 V617F Mutation by LightCycler PCR and Probe Dissociation Analysis

This publication has 10 references indexed in Scilit:

• The JAK2V617F activating mutation occurs in chronic myelomonocytic leukemia and acute myeloid leukemia, but not in acute lymphoblastic leukemia or chronic lymphocytic leukemia
  Blood, 2005
• Concomitant neutrophil JAK2^V617F mutation screening and PRV‐1 expression analysis in myeloproliferative disorders and secondary polycythaemia
  British Journal of Haematology, 2005
• JAK2^V617F mutation in essential thrombocythaemia: clinical associations and long‐term prognostic relevance
  British Journal of Haematology, 2005
• JAK2Mutations in Myeloproliferative Disorders
  New England Journal of Medicine, 2005
• Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders
  Blood, 2005
• The JAK2V617F Tyrosine Kinase Mutation in Myeloproliferative Disorders: Status Report and Immediate Implications for Disease Classification and Diagnosis
  Mayo Clinic Proceedings, 2005
• Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
  Published by Elsevier ,2005
• A Gain-of-Function Mutation ofJAK2in Myeloproliferative Disorders
  New England Journal of Medicine, 2005
• A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera
  Nature, 2005
• Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
  The Lancet, 2005